RECRUITINGOBSERVATIONAL
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Pforzheim Tricuspid Valve Registry: A Real-world Observational Trial Evaluating Outcomes in Patients Treated With the Abbott TriClip™ Device in Helios Klinikum Pforzheim
About This Trial
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
Who May Be Eligible (Plain English)
Who May Qualify:
- Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
- Subjects eligible to receive the TriClip™
- Subjects must provide written willing to sign a consent form prior to study procedure.
Who Should NOT Join This Trial:
- Subjects participating in another clinical study that may impact the follow-up or results of this study.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
* Subjects eligible to receive the TriClip™
* Subjects must provide written informed consent prior to study procedure.
Exclusion Criteria:
* Subjects participating in another clinical study that may impact the follow-up or results of this study.
Treatments Being Tested
PROCEDURE
Transcatheter edge-to-edge tricuspid valve repair
Percutaneous edge to edge repair of tricuspid valve using the TriClip system
Locations (1)
Helios Klinikum Pforzheim
Pforzheim, Germany